A research team from the Hospital Clínic-IDIBAPS, the Catalan Institute of Oncology (ICO) and the Vall d’Hebron Institute of Oncology (VHIO) has participated in an international study that demonstrates the efficacy of a new drug for metastatic breast cancer with low expression of HER2, the protein found on the outside of tumor cells. This treatment, [...]

6 June 2022